Jeff Yass’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.2M Buy
248,100
+243,100
+4,862% +$18.4M ﹤0.01% 2699
2026
Q2
$366K Sell
5,000
-11,200
-69% -$770K ﹤0.01% 10614
2026
Q1
$1.04M Sell
16,200
-4,300
-21% -$298K ﹤0.01% 7800
2025
Q4
$1.63M Buy
20,500
+13,300
+185% +$1.12M ﹤0.01% 6066
2025
Q3
$476K Buy
+7,200
New +$428K ﹤0.01% 9074
2025
Q2
– Sell
-6,200
Closed -$308K – 13177
2025
Q1
$308K Sell
6,200
-13,200
-68% -$734K ﹤0.01% 10022
2024
Q4
$1.23M Buy
19,400
+15,100
+351% +$873K ﹤0.01% 6456
2024
Q3
$211K Buy
+4,300
New +$202K ﹤0.01% 10358
2024
Q2
– Sell
-59,600
Closed -$3.71M – 12628
2024
Q1
$3.71M Buy
+59,600
New +$3.86M ﹤0.01% 4135
2022
Q3
– Sell
-487
Closed -$25K – 13646
2022
Q2
$25K Buy
+487
New +$21.5K ﹤0.01% 12298
2022
Q1
– Sell
-523
Closed -$46K – 13481
2021
Q4
$46K Sell
523
-57
-10% -$5.59K ﹤0.01% 12589
2021
Q3
$70K Sell
580
-127
-18% -$17.4K ﹤0.01% 12224
2021
Q2
$137K Buy
+707
New +$232K ﹤0.01% 11903

Other funds holding IRON

Jeff Yass's IRON Position: Q3 2026 in Review

Jeff Yass increased its Disc Medicine (IRON) stake by 102% in Q3 2026, buying an estimated $225K and bringing the position to 5,886 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #10375.

Jeff Yass first reported a position in IRON in Q1 2021 and has held it in 20 quarters since. The position peaked at $4.02M in Q2 2025. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • Jeff Yass held 5,886 shares of Disc Medicine worth $385K as of Q3 2026.
  • Jeff Yass bought 2,972 Disc Medicine shares in Q3 2026, an estimated $225K.
  • Disc Medicine made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10375 holding.
  • Jeff Yass first reported a position in Disc Medicine in Q1 2021 and has held it in 20 quarters since.
  • Jeff Yass's Disc Medicine position peaked at $4.02M in Q2 2025.
  • 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.